ABT vs LSCC · P/E 25, rev $44.33B vs P/E 1085, rev $509.4M
Abbott Laboratories (ABT) versus Lattice Semiconductor Corporation (LSCC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Lattice Semiconductor Corporation (LSCC) is a semiconductors company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported LSCC revenue for 2024-12-28 was $509.4M. Net income was $61.1M. Revenue was down 30.9% from 2023-12-30 to 2024-12-28. LSCC currently screens at market cap $20.81B and trailing P/E 1085.1.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. LSCC currently screens at market cap $20.81B and trailing P/E 1085.1.
Not investment advice. Open the ABT and LSCC stock pages for the full models.
Not investment advice.